v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Sales $ 472 $ 652 $ 1,093 $ 7,261
Cost of goods sold 470 539 1,015 6,783
Gross profit 2 113 78 478
Costs and expenses:        
General and administrative costs 9,201 1,174 10,845 3,674
Research and development costs 473 31 832 1,044
Transaction costs 5,413 6,434
Total costs and expenses 15,087 1,205 18,111 4,718
Loss from operations (15,085) (1,092) (18,033) (4,240)
Other income (expenses):        
Interest income 8 1 8 1
Interest expense (103) (352) (832) (1,292)
Loss on debt extinguishment (3) (1,355)
Loss (gain) on issuance of warrant liability 1,500 (123,941)
Change in fair value of warrant liability (23,161)
Net loss (13,683) (1,443) (167,314) (5,531)
Non-controlling interest 47 47
Net loss attributable to common stockholders $ (13,636) $ (1,443) $ (167,267) $ (5,531)
Net loss per common share - basic $ (0.74) $ (1.30) $ (24.02) $ (5.02)
Net loss per common share - diluted $ (0.74) $ (1.30) $ (24.02) $ (5.02)
Weighted average common shares outstanding - basic 18,431,397 1,108,832 6,966,392 1,101,849
Weighted average common shares outstanding - diluted 18,431,397 1,108,832 6,966,392 1,101,849

Source